Understanding Sickle Cell Disease: A Genetic Blood Disorder

Last updated on:

January 30, 2026

Most people know that traits like height, eye color, or skin tone are passed down through families. But genes don’t just shape how we look – they also carry instructions for how our bodies function at the cellular level. When a gene carries an error, even a tiny one, the consequences can ripple through nearly every system in the body. Sickle Cell Disease (SCD) is one of the clearest examples of this. It begins with a single mutation in a single gene and ends up affecting how blood carries oxygen, how pain occurs, and how organs survive over a lifetime.

The role of genes and heredity
The function of red blood cells and hemoglobin
The HBB gene mutation
From disc to sickle: the shape change
Consequences of the sickle shape
Vaso-occlusion and pain crises
Hemolytic anemia
Sickle Cell Disease as a recognized disability: the RPwD Act 2016
Why understanding SCD matters in education

The role of genes and heredity

Every living cell in the human body contains DNA – the biological instruction manual that governs how cells grow, function, and reproduce. Within DNA, genes are the specific segments that carry instructions for making proteins. These proteins do the actual work inside the body, from building muscle to regulating chemical processes.

Heredity is the mechanism through which these genetic instructions are passed from parents to their children. Each parent contributes one copy of each gene to their child. For most genes, having one normal copy and one altered copy is enough to maintain healthy function. But some conditions, including Sickle Cell Disease, follow what is called an autosomal recessive inheritance pattern – meaning a child must inherit the altered gene from both parents to actually develop the disease. According to MedlinePlus Genetics, both copies of the gene in each cell must carry a variant for the disorder to occur. A child who inherits just one copy becomes a carrier – they can pass the gene on to their own children but typically show no symptoms themselves.

This inheritance pattern has a direct statistical implication: when both parents carry one copy of the sickle cell gene (sickle cell trait), each pregnancy carries a 25% chance of the child having Sickle Cell Disease, a 50% chance of the child being a carrier, and a 25% chance of the child inheriting neither altered gene.

The function of red blood cells and hemoglobin

To understand how Sickle Cell Disease causes harm, it helps to first understand what healthy red blood cells do. Red blood cells (RBCs) are the most abundant cells in the blood. Their primary job is to collect oxygen from the lungs and deliver it to every tissue and organ in the body, while simultaneously carrying carbon dioxide back to the lungs to be exhaled. This continuous exchange keeps the body’s cells alive and functioning.

The molecule that makes this oxygen transport possible is hemoglobin – a protein found inside every red blood cell. Hemoglobin is made up of four protein subunits: typically two alpha-globin chains and two beta-globin chains. It is the beta-globin component that is directly relevant to Sickle Cell Disease. As explained by MedlinePlus, the HBB gene provides the instructions for making beta-globin, one of the key building blocks of hemoglobin. Healthy, normal red blood cells are round and flexible – their disc-like shape allows them to squeeze through even the narrowest blood vessels without difficulty.

The HBB gene mutation

Sickle Cell Disease is caused by a specific mutation in the HBB gene, located on chromosome 11. This is not a large structural change – it is a single-letter alteration in the genetic code, known as a point mutation. According to MedlinePlus Genetics, this particular mutation causes the amino acid glutamic acid to be replaced by the amino acid valine at position 6 of the beta-globin protein – a change written in scientific notation as Glu6Val or E6V.

That substitution of one amino acid for another may seem minor in isolation. But proteins are extraordinarily sensitive to their exact molecular composition. When valine replaces glutamic acid in the beta-globin chain, the resulting protein – known as hemoglobin S (HbS) – behaves very differently from normal hemoglobin. The altered subunits become “sticky” and tend to clump together, forming long, rigid chains inside the red blood cell. This structural failure is what sets the entire cascade of Sickle Cell Disease into motion.

The NIH’s Genes and Disease resource notes that SCD is an autosomal recessive disease caused by this point mutation in the HBB gene found on chromosome 11. Carrier frequency of the HBB mutation varies significantly around the world, with high rates associated with regions where malaria has historically been endemic – because carrying one copy of the sickle cell gene offers some protective advantage against the malaria parasite.

From disc to sickle: the shape change

Under normal oxygen conditions, hemoglobin S behaves reasonably well. The problem emerges when oxygen levels in the blood drop – a situation that occurs naturally during physical exertion, illness, dehydration, or even at high altitudes. In these conditions, HbS molecules begin to polymerize – they link together into long, stiff filaments that physically deform the red blood cell from its normal flexible disc shape into a rigid, elongated crescent or sickle shape.

As Cleveland Clinic explains, normal red blood cells are donut-shaped and flexible enough to navigate the twists and turns of blood vessels. Changes in the HBB gene produce abnormal versions of hemoglobin called hemoglobin S, causing red blood cells to become stiff, sticky, and sickle-shaped. This shape change is not merely cosmetic – it fundamentally alters everything the red blood cell can and cannot do.

Consequences of the sickle shape

The transformation of red blood cells into sickle cells triggers two major, interconnected problems that define the clinical experience of Sickle Cell Disease.

Vaso-occlusion and pain crises

Sickle cells are stiff and sticky – two properties that make them dangerous inside the circulatory system. According to patient education resources on sickle cell complications, sickle-shaped red blood cells can damage blood vessels and block blood flow throughout the body. This blockage is called vaso-occlusion, and it prevents organs and tissues from receiving the oxygen they need. The result is intense, sometimes debilitating pain – referred to clinically as a vaso-occlusive crisis (VOC) or pain crisis.

Mayo Clinic describes these episodes of extreme pain as a major symptom of sickle cell anemia, occurring when sickle-shaped cells block blood flow through tiny blood vessels to the chest, abdomen, and joints. Pain crises can last anywhere from a few hours to several days and may require hospitalization. Repeated episodes of vaso-occlusion cause cumulative, progressive damage to vital organs including the lungs, kidneys, spleen, and brain. Data shows that 1 in 4 adults with sickle cell disease will experience a stroke by age 45 – a direct result of blocked blood vessels in the brain.

Hemolytic anemia

The second major consequence of the sickle shape is the dramatically shortened lifespan of sickle cells. Normal red blood cells survive for approximately 90 to 120 days before being naturally recycled. Sickle cells, because of their rigid and fragile structure, break down in as little as 10 to 20 days. Research published in PMC confirms that SCD causes chronic hemolytic anemia, characterized by the accelerated destruction of red blood cells, which leads to persistent fatigue, weakness, paleness, and shortness of breath.

The body’s bone marrow simply cannot produce new red blood cells fast enough to replace those being destroyed at this accelerated rate. This creates a chronic and persistent shortage of functional red blood cells – a condition known as anemia. Since red blood cells are the vehicles for oxygen delivery, chronic anemia means the body’s tissues are perpetually under-oxygenated, even between pain crises. This ongoing oxygen deficiency is why people with SCD often experience constant fatigue, difficulty concentrating, and reduced physical endurance as baseline conditions – not just during acute episodes.

Sickle Cell Disease as a recognized disability: the RPwD Act 2016

The medical impact of Sickle Cell Disease extends well beyond individual health. It affects a person’s ability to work, study, and participate fully in daily life. Recognizing this, the Indian government took a significant legislative step with the Rights of Persons with Disabilities (RPwD) Act, 2016.

As announced by the Press Information Bureau of India, the RPwD Act 2016 expanded the recognized categories of disability from 7 to 21, explicitly including three blood disorders for the first time: Thalassemia, Hemophilia, and Sickle Cell Disease. The Act formally defines Sickle Cell Disease as a hemolytic disorder characterised by chronic anemia, painful events, and various complications due to associated tissue and organ damage.

This definition is medically precise and captures the three-dimensional burden of the disease: the ongoing destruction of red blood cells (hemolysis), the persistent shortage of those cells (chronic anemia), and the episodic and cumulative harm to the body’s tissues and organs. The Diversity and Equal Opportunity Centre notes that individuals assessed at 40% disability or above are entitled to a Disability Certificate under the Act, which provides legal protections against discrimination in employment and access to higher education.

In India, SCD disproportionately affects tribal and Dalit communities, with carrier rates as high as 40% in some regions. The Act’s recognition of SCD as a disability represents a meaningful step toward legal protection and social inclusion for these communities – though ongoing discussions about the scope of reservations and the accessibility of certification processes continue to shape policy.

Why understanding SCD matters in education

Sickle Cell Disease is not rare – globally, approximately 300,000 children are born with SCD each year, making it one of the most prevalent serious genetic disorders in the world. Students, teachers, and healthcare workers who understand its genetic origins, its physiological mechanisms, and its human impact are far better placed to support individuals living with this condition in classrooms, workplaces, and communities.

Recognizing that a student’s chronic fatigue, frequent absences, or episodes of acute pain may stem from a cellular-level biological process – not a behavioral choice – is the difference between exclusion and meaningful inclusion. Understanding SCD means understanding that a single point mutation in a single gene can reshape an entire life.

What do you think? If a student with Sickle Cell Disease frequently misses class due to pain crises, what specific accommodations could a teacher or institution put in place to ensure they don’t fall behind? And given that the RPwD Act 2016 formally recognizes SCD as a disability, do you think current awareness levels among educators in India are adequate to translate that legal recognition into real support in the classroom?

References

PDF 📄

Understanding Sickle Cell Disease: A Genetic Blood Disorder

Table of Contents

The role of genes and heredity 🔗

The function of red blood cells and hemoglobin 🔗

The HBB gene mutation 🔗

From disc to sickle: the shape change 🔗

Consequences of the sickle shape 🔗

Vaso-occlusion and pain crises 🔗

Hemolytic anemia 🔗

Sickle Cell Disease as a recognized disability: the RPwD Act 2016 🔗

Why understanding SCD matters in education 🔗